Skip to main content
. 2022 Mar 19;9(3):433. doi: 10.3390/children9030433

Table 4.

Aesthetic properties evaluation based on FDI criteria.

Aesthetic Properties
Activa BioActive SDR Bulk-Fill
n (%) n (%)
FDI CRITERIA T0 T1 T2 T3 T0 T1 T2 T3
1—CLINICALLY EXCELLENT 90 (100) 80 (89) 65 (72) 60 (67) 89 (100) 73 (82) 57 (64) 53 (60)
2—CLINICALLY GOOD 0 (0) 10 (11) 23 (26) 27 (30) 0 (0) 16 (18) 31 (35) 33 (37)
3—CLINICALLY SUFFICIENT 0 (0) 0 (0) 1 (1) 1 (1) 0 (0) 0 (0) 0 (0) 1 (1)
4—CLINICALLY UNSATISFACTORY 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
5—CLINICALLY POOR 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
FAILED 0 (0) 0 (0) 1 (1) 2 (2) 0 (0) 0 (0) 1 (1) 2 (2)